Literature DB >> 19117816

Cassette analysis of eight beta-blockers in bovine eye sclera, choroid-RPE, retina, and vitreous by liquid chromatography-tandem mass spectrometry.

Rajendra S Kadam1, Uday B Kompella.   

Abstract

A simple, selective, and sensitive LC-MS/MS method was developed for the simultaneous extraction and determination of eight beta-blockers (atenolol, sotalol, nadolol, pindolol, timolol, metoprolol, betaxolol and propranolol) in various bovine eye tissues including sclera, choroid-RPE, retina, and vitreous. The analytes were extracted by liquid-liquid extraction after samples were alkalinized with 2% NaOH solution in water. The chromatographic separation was performed on a Hypersil-ODS C18 column (100 mm x 2.1 mm, 3.9 microm) using a gradient mixture of (A) 5 mM ammonium formate in water (pH 3.5 adjusted with formic acid) and (B) acetonitrile:methanol (75:25) containing 0.02% triethyl amine (pH 4.0; adjusted with formic acid) as mobile phase at a flow rate of 0.4 ml/min. The compounds were ionized in the positive electrospray ionization (ESI) mode and detected in the multiple reaction monitoring (MRM) mode. The average recoveries in all four eye tissues for all beta-blockers were >82%, except for sotalol (>51%). The matrix effect for beta-blockers ranged from 81 to 110% in the four eye tissues. This analytical method was validated and applied successfully for simultaneous quantification of the beta-blockers in sclera after tissue exposure using cassette dosing method. The calibration curve was linear in the range of 10-2000 ng/ml for all analytes, with the correlation coefficient >0.996. Intra-day and inter-day precision (% CV) was less than 15%, and accuracy ranged from 85 to 110% for all analytes. Scleral uptake was the lowest for sotalol and atenolol, two hydrophilic beta-blockers, and the highest for propranolol, a lipophilic beta-blocker.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19117816     DOI: 10.1016/j.jchromb.2008.12.027

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  7 in total

1.  Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models.

Authors:  Rajendra S Kadam; Narayan P S Cheruvu; Henry F Edelhauser; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-23       Impact factor: 4.799

2.  Immunohistochemical and functional characterization of peptide, organic cation, neutral and basic amino acid, and monocarboxylate drug transporters in human ocular tissues.

Authors:  Rajendra S Kadam; Sunil K Vooturi; Uday B Kompella
Journal:  Drug Metab Dispos       Date:  2012-11-20       Impact factor: 3.922

3.  Brain mitochondrial drug delivery: influence of drug physicochemical properties.

Authors:  Shelley A Durazo; Rajendra S Kadam; Derek Drechsel; Manisha Patel; Uday B Kompella
Journal:  Pharm Res       Date:  2011-07-28       Impact factor: 4.200

4.  Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve.

Authors:  Rajendra S Kadam; Uday B Kompella
Journal:  J Pharmacol Exp Ther       Date:  2009-11-19       Impact factor: 4.030

5.  Development of novel in silico model to predict corneal permeability for congeneric drugs: a QSPR approach.

Authors:  Charu Sharma; Thirumurthy Velpandian; Nihar Ranjan Biswas; Niranjan Nayak; Rasik Bihari Vajpayee; Supriyo Ghose
Journal:  J Biomed Biotechnol       Date:  2011-02-20

6.  Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes.

Authors:  Rajendra S Kadam; Jason Williams; Puneet Tyagi; Henry F Edelhauser; Uday B Kompella
Journal:  Mol Vis       Date:  2013-05-30       Impact factor: 2.367

7.  Comprehensive evaluation of formulation factors for ocular penetration of fluoroquinolones in rabbits using cassette dosing technique.

Authors:  Charu Sharma; Nihar R Biswas; Shreesh Ojha; Thirumurthy Velpandian
Journal:  Drug Des Devel Ther       Date:  2016-02-22       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.